Clinical Training Articles & Analysis
30 news found
Anuncia Medical Inc. (“Anuncia” or the “Company”), a Company specializing in advancing innovations for implantable and external cerebrospinal fluid (CSF) management systems, is pleased to announce the successful first implant of the Company’s FDA-cleared ReFlow™ Mini Flusher device in tandem with a “sonolucent” cranial plate (Clearfit® Cover, ...
Even before Zachary was born nearly 11 years ago, his parents Sherry and Jason knew that he was going to be a special boy – and a wonderful sibling to a twin sister! Zachary was born with spina bifida and hydrocephalus, both of which were diagnosed while in utero. As with many children in the hydrocephalus community, most parents have never heard of the condition, nor understand how it ...
Intermountain Primary Children’s Hospital First in the Country to Implant this Next Generation FDA-Cleared Device Company Welcomes Vice President of Sales & Marketing, Mark Geiger, Who Lives with Hydrocephalus Anuncia Medical Inc. (“Anuncia” or the “Company”), a Company specializing in advancing innovations for implantable and external cerebrospinal fluid ...
After struggling to conceive a child for what felt like ages, Miranda of Moncks County, South Carolina finally fell pregnant - a miracle that quickly turned into horror when she delivered at 24 weeks in late 2015. At just 1 pound and 12 ounces, her son, Sutton, arrived with life-threatening health issues, including hydrocephalus - a neurological disorder caused by an abnormal buildup of ...
Osso VR, now the largest and fastest-growing virtual reality (VR) company in healthcare, today announced the appointment of two new executives to its growing team: Stacie Frederick as Chief Technology Officer (CTO) and Heather Gervais as Chief Revenue Officer (CRO). Frederick brings over a decade of experience leading product and engineering for multiple high-profile companies and ...
Osso VR, now the largest and fastest-growing virtual reality (VR) company in healthcare, and the American College of Cardiology (ACC), a global nonprofit dedicated to transforming cardiovascular care, today announced a new collaboration to develop an immersive, VR-enabled training program for cardiovascular professionals. The collaboration builds upon the ACC’s long tradition of ...
Anuncia Medical, Inc., announced that the U.S. Food and Drug Administration (FDA) cleared the ReFlow® System Mini for the treatment of patients with hydrocephalus and other cerebrospinal fluid (CSF) disorders that require shunting. Anuncia Medical announced FDA clearance of ReFlow® System Mini for the treatment of cerebrospinal fluid (CSF) disorders. The FDA 510(k) clearance allows ...
Osso VR, now the largest and fastest-growing virtual reality (VR) company in healthcare, today announced the results of a new study published in the Journal of Surgical Education demonstrating the effectiveness of VR training for medical residents learning complex orthopedic surgical procedures. The study, led by orthopedic surgeons at Community Memorial Health System in California, divided a ...
Tissuemed Ltd. was recently able to support the 2nd African Head and Neck Society (AfHNS) Conference. The company’s TissuePatch surgical sealant film is a useful adjunct to ENT and Head and and Neck Surgery, often used to seal tissue surfaces and therefore minimise the need for postoperative drainage. The AfHNS is a relatively new Society with the mission to: improve outcomes of ...
Cordis-X today announced an $11.5 million Series F investment in Adient Medical, maker of a next-generation absorbable inferior vena cava (IVC) filter that provides protection against pulmonary embolisms (PE). The device is designed to avoid well-documented risks of perforation, migration, fracture, and thrombosis currently associated with IVC filters. Such safety issues have been the focus of ...
The double-blinded trial is testing Calviri’s vaccine aimed at broadly preventing cancers in dogs. The VACCS just completed year three of the planned five year trial. It is being conducted at three leading canine oncology centers – the Flint Animal Cancer Center at Colorado State University, the School of Veterinary Medicine at University of Wisconsin-Madison and the University of ...
ByCalviri
CoapTech LLC announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health (NIH) awarded the company a two-year, $1.2M R44 Small Business Innovation Research (SBIR) Phase II grant on August 29, 2019. This builds on a $225,000 Phase I SBIR R43 grant and a $200,000 Maryland Industrial Partnerships (MIPS) grant awarded to ...
ByCoapTech
With the update 2.0 of the virtual reality therapy system CUREO® of the med-tech company CUREosity from Düsseldorf, therapy is optimized with intuitive, digital and efficient tools. Based on user analysis and evaluation of feedback from clinics, therapists and patients, we have further developed our system to relieve therapists. The update has been officially available since January 31. ...
ATHENS, Greece, November 24, 2021 Following our successful cooperation since 2018, we are excited to announce that RTsafe and Medical Physics Limited expand their cooperation by entering into a partnership agreement under which Medical Physics Limited will be the agent of RTsafe’s innovative solutions for quality assurance in radiotherapy in the United Kingdom. Moreover, our partnership ...
ByRTsafe
Saluda Medical Pty Limited (“Saluda Medical”), the pioneer in neuromodulation platform of closed-loop technologies designed to achieve unparalleled outcomes for patients suffering from neurological conditions, today announced the expansion of the Company’s leadership team. Both executives bring years of professional accomplishments from the health technology industry and will ...
SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapies for chronic autoimmune diseases, today announced the appointment of Amy Derosier as Vice President of Clinical Affairs. “Amy’s extensive experience in successfully designing and executing clinical trials for novel medical devices complements that of our CMO, Dr. David Chernoff, who has extensive ...
Deep Genomics, the leading AI therapeutics company, welcomes Tal Zaks, M.D., Ph.D., to its Strategic Advisory Board, effective today. Deep Genomics uses AI and machine learning to program and prioritize transformational nucleotide-based therapeutics for genetic diseases. As Chief Medical Officer at Moderna, Zaks successfully led a team that pioneered the field of mRNA therapeutics and drove ...
MicroPort Orthopedics, a global leader in orthopedic devices and technologies, today announces that C. Lowry Barnes, MD, Chair of Orthopaedics at the University of Arkansas for Medical Sciences Health, has officially joined the company’s leadership team as Medical Director. Dr. Barnes is a board-certified, fellowship-trained total joint surgeon with a special interest in hip and knee ...
The Vaccine Against Canine Cancer Study (VACCS) trial (www.vaccs.org) reported its formal two-year evaluation of the safety of a vaccine to prevent cancer in healthy dogs. The largest interventional trial in dogs, it is sponsored by the Open Philanthropy Project, with additional support from Calviri, Inc., a biotech spinout from Arizona State University. The VACCS trial intends to enroll up to ...
ByCalviri
The disruptive impact of the Covid-19 pandemic on medical services has been a central concern across our industry. The global health strategy, backed by guidance from the National Institutes of Health and World Health Organization, has so far focused on flattening the epidemiological curve. By doing so, we’ll prevent healthcare services, resources, and medical staff from being overwhelmed. ...